Human medicines European public assessment report (EPAR): Teizeild, teplizumab, Date of authorisation: 08/01/2026, Status: Authorised

Human medicines European public assessment report (EPAR): Vfend, voriconazole, Date of authorisation: 19/03/2002, Revision: 58, Status: Authorised

Guideline on quality aspects of mRNA vaccines for veterinary use

Opinion on medicine for use outside EU: Lenacapavir Gilead, lenacapavir sodium, HIV Infections,HIV-1, 24/07/2025 Positive opinion

ICH Q2(R2) Validation of analytical procedures - Scientific guideline

Recruitment procedure opens for next Executive Director of the European Medicines Agency

Human medicines European public assessment report (EPAR): Apremilast Accord, apremilast, Date of authorisation: 19/04/2024, Revision: 3, Status: Authorised

Draft guideline on quality aspects of mRNA vaccines for veterinary use

Draft guideline on quality aspects of mRNA vaccines for veterinary use

PSUSA/00001307/202507